Don't know what NK is but I think I have been reading too many...

Don't know what NK is but I think I have been reading too many of the fiercebiotech preclinical takeover deal stories so yes I was inferring that there may be nothing but a smoking pile of cash by 2019 if they are successful in demonstrating they have the worlds best FPP delivery platform. The repeatability of the platform has been well discussed so the question simply is - whats the price at the mouse stage and is that enough to temp all of us out of the (still considerable) future risk. Going beyond this stage will require another far more substantial chunk of cash IMHO - it could be funded deal to deal but are we all really that patient? When I have been privileged to be involved in takeovers the human impulse to take the money and run is strong. Go and revalue you holding now at 5c , 7.5c , 10c & 15c - maybe as high as 20c but somewhere along that line the vast majority of people will take the cash. Yeah we miss out on $1+ but there would be something between $30m-$300m that would need to be spent along the way to enter the billion dollar MCAP - possible but it ain't likely that existing PYC holders can find that and for most 15c would represent 3x to 10x which is not a bad result.